Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Large B-cell Lymphoma, c-MYC Positive”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT06249191
What this trial is testing

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaHigh Grade B-Cell Lymphoma
OHSU Knight Cancer Institute 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652139
What this trial is testing

Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT05583149
What this trial is testing

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

Who this might be right for
Refractory Aggressive B-cell LymphomasRefractory B-Cell Non-Hodgkin LymphomaAggressive B-cell NHL+10 more
Patrick C. Johnson, MD 28
Testing effectiveness (Phase 2)Ended earlyNCT01914718
What this trial is testing

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fudan University 26
Early research (Phase 1)Ended earlyNCT03132584
What this trial is testing

Cyclophosphamide and Alemtuzumab In Lymphoma

Who this might be right for
Non Hodgkin LymphomaHigh-grade B-cell LymphomaDiffuse Large B Cell Lymphoma
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT01092182
What this trial is testing

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

Who this might be right for
Burkitt LymphomaDiffuse Large B-cell Lymphoma, c-MYC PositivePlasmablastic Lymphoma
National Cancer Institute (NCI) 194
Early research (Phase 1)Ended earlyNCT02700022
What this trial is testing

A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas

Who this might be right for
Diffuse Large B-cell LymphomaFollicular LymphomaBurkitt Lymphoma
UNC Lineberger Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT05498636
What this trial is testing

SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL With p53 and/or c-Myc Expression

Who this might be right for
DLBCL
The Affiliated Hospital of Qingdao University 67
Early research (Phase 1)Study completedNCT01897012
What this trial is testing

Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas

Who this might be right for
MYC PositiveRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Burkitt Lymphoma+14 more
National Cancer Institute (NCI) 26